MDMA President and CEO, Keynote Presenter at LifeScience Alley Conference

Mark Leahey, MDMA President and CEO, was a keynote presenter at the 8th Annual LifeScience Alley conference in Minneapolis on December 9th. Leahey addressed the changing landscape at FDA, which included FDA's new leadership, the future of the 510(k) program, the FDA advisory panel process and its need for reform, and recent congressional activity. The Conference is the largest regional life science program in the US, with more than 1500 attendees from nearly 30 states and a dozen countries. Pictured: Mark Leahey and Don Gerhardt, President and CEO, LifeScience Alley.